Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab Phase 2b in Uncontrolled Asthma
NCT01854047Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2013
- Primary completion
- Nov 2014
- Modality
- Monoclonal Antibodies
- Countries
- 16
01
Overview
A Phase 2 trial of dupilumab in asthma, sponsored by Sanofi. Started Jun 2013; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01854047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01854047.